Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14926 - 14950 of 15134 in total

4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol

Experimental

3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile

Experimental

REP8839

REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
Investigational

2,5-Dimethoxy-4-(n)-propylthiophenethylamine

Experimental
Illicit

4-Bromo-2,5-dimethoxyphenethylamine

Experimental
Illicit

R048-8071

Experimental

1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene

Experimental

2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione

Experimental

4-Phenylbutylamine

Experimental

2,3-Difluorobenzyl Alcohol

Experimental

Phenethylamine

Experimental

Soneclosan

Experimental

3-Phenylpropylamine

Experimental

2,5-di-tert-butylhydroquinone

Experimental

(S)-4-Nitrostyrene oxide

Experimental

(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide

Experimental

p-Cumylphenol

Experimental

1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE

Experimental

5-PENTYL-2-PHENOXYPHENOL

Experimental

N-methyl-1-(2-thiophen-2-ylphenyl)methanamine

Experimental

1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene

Experimental

4-(2-aminoethyl)-2-cyclohexylphenol

Experimental

4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile

Experimental

4,4'-Dihydroxybenzophenone

Experimental

6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL

Experimental
Displaying drugs 14926 - 14950 of 15134 in total